Search

Search Results
Results 81 - 90 of 105 for Male breast cancer
  • Esomeprazole Viatris
    Drug - 24 Mar 2023
    Consumer Medicine Information (CMI) about Esomeprazole Viatris (esomeprazole) intended for persons living in Australia.
  • Diphereline
    Drug - 15 Mar 2023
    Consumer Medicine Information (CMI) about Diphereline (triptorelin embonate) intended for persons living in Australia.
  • Brukinsa
    Drug - 10 Mar 2023
    Consumer Medicine Information (CMI) about Brukinsa intended for persons living in Australia.
  • Fludara Oral
    Drug - 16 Jan 2023
    Consumer Medicine Information (CMI) about Fludara Oral intended for persons living in Australia.
  • Esopreze
    Drug - 10 Jan 2023
    Consumer Medicine Information (CMI) about Esopreze intended for persons living in Australia.
  • Nexium
    Drug - 10 Jan 2023
    Consumer Medicine Information (CMI) about Nexium (Esomeprazole magnesium trihydrate) intended for persons living in Australia.
  • Alunbrig
    Drug - 7 Dec 2022
    Consumer Medicine Information (CMI) about Alunbrig intended for persons living in Australia.
  • Xospata
    Drug - 15 Sep 2022
    Consumer Medicine Information (CMI) about Xospata intended for persons living in Australia.
  • Xtandi
    Drug - 5 Aug 2022
    Consumer Medicine Information (CMI) about Xtandi intended for persons living in Australia.
  • Adriamycin
    Drug - 13 Jul 2022
    Consumer Medicine Information (CMI) about Adriamycin (Doxorubicin hydrochloride) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback